Results 221 to 230 of about 69,857 (321)

Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice

, 2015
Emil Zeynalov, Susan Jones, Jeong-Woo Seo, Lawrence D. Snell, J. Paul Elliott   +4 more
openalex   +2 more sources

Pregnancy complicated by a large prolapsing cervical fibroid requiring antepartum vaginal myomectomy—A case report

International Journal of Gynecology &Obstetrics, Volume 172, Issue 2, Page 1268-1270, February 2026.
Samantha Taylor, Ashley Tshala, Violaine Marcoux   +2 more
wiley   +1 more source

To VAE or not to VAE: outcomes of radial scars/complex sclerosing lesions and papillary lesions without atypia in the King's College Hospital breast service (2017–2023)

Histopathology, Volume 88, Issue 3, Page 583-590, February 2026.
Radial scars/complex sclerosing lesions (RS/CSL) without atypia have a low upgrade rate (1%) and could possibly be monitored radiologically, thus avoiding excision. Papillary lesions without atypia have a higher upgrade rate (4%) and should continue to undergo vacuum excision until we better understand these heterogeneous lesions.
Amy Llewellyn, Adam Brown, Juliet Morel, Kalnisha Naidoo   +3 more
wiley   +1 more source

A Novel Missense Mutation of Arginine Vasopressin Receptor 2 in a Chinese Family with Congenital Nephrogenic Diabetes Insipidus: X-Chromosome Inactivation in Female CNDI Patients with Heterozygote 814A>G Mutation.

Biomed Res Int, 2022
Zang L, Gong Y, Li Y, Dou J, Lyu Z, Su X, Zhang Y, Mu Y.   +7 more
europepmc   +1 more source

Asymmetric Catalytic Hydrogenation toward a Value‐Added Chiral Building Block: Optically Active γ‐Butyrolactone Scaffold from Renewable and Synthetic Derived Feedstocks

European Journal of Organic Chemistry, Volume 29, Issue 3, January 22, 2026.
This brief compendium summarizes the most successful asymmetric hydrogenation strategies for the preparation of chiral monocyclic γ‐lactone derivatives from keto acids and keto esters, with emphasis on their relevance for large‐scale production and high enatioselectivities. This article provides a brief compendium on the production of chiral monocyclic
Marta Feliz, Maria J. Sabater
wiley   +1 more source

Dimerization Between Vasopressin V1b and Corticotropin Releasing Hormone Type 1 Receptors

, 2007
Sharla F. Young, Cristiana Griffante, Greti Aguilera   +2 more
openalex   +2 more sources

From gonadotropin-inhibitory hormone to SIFamides: Are echinoderm SALMFamides the "missing link" in a bilaterian family of neuropeptides that regulate reproductive processes? [PDF]

, 2013
Bentley, Bonini, Broeck, Dockray, Díaz-Miranda, Elphick, Elphick, Elphick, Elphick, Elphick, Elphick, Elphick, Elshourbagy, Gouarderes, Hartenstein, Hewes, Hinuma, Janssen, Jekely, Jorgensen, Krishnan, Li, Liu, Maurice R. Elphick, Melarange, Melarange, Mirabeau, Mita, Mita, Mollereau, Newman, Newman, Perry, Putnam, Rowe, Satake, Terhzaz, Tsutsui, Ubuka, Ubuka, Van Kesteren, Veenstra, Veenstra, Vilim, Yang, Yasuda, Zhang   +46 more
core   +1 more source

Selective blockade of vasopressin V2 receptors reveals significant V2‐mediated water reabsorption in Brattleboro rats with diabetes insipidus [PDF]

, 2001
Brigitte Pouzet, Claudine Serradeil‐Le Gal, Nadine Bouby, Jean‐Pierre Maffrand, Gérard Le Fur, Lise Bankir   +5 more
openalex   +1 more source

Arginine-Vasopressin Neurons in the Rat Hypothalamus Produce Neurokinin B and Co-express the Tachykinin NK-3 Receptor and Angiotensin II Type 1 Receptor.

, 2001
Takashi Hatae, Hitoshi Kawano, Vladimir Karpitskiy, James E. Krause, Sadahiko Masuko   +4 more
openalex   +2 more sources

An Overview of SR121463, a Selective Non‐Peptide Vasopressin V₂Receptor Antagonist [PDF]

, 2001
C. Serradeil‐Le Gal
openalex   +1 more source